Neutralizing antibodies (NABS) and interferon beta-1b therapy of multiple sclerosis

FG 7142: is this validated tool to study anxiety now forgotten?

Journal of neural transmission (Vienna, Austria : 1996)·2020

Classical dopamine agonists.

Journal of neural transmission (Vienna, Austria : 1996)·2019

Japanese medicine and Berlin: a very special and successful relationship.

Journal of neural transmission (Vienna, Austria : 1996)·2017

The "Madness" of Friedrich Hölderlin: an iatrogenic intoxication.

Journal of neural transmission (Vienna, Austria : 1996)·2017

Lisuride, a dopamine receptor agonist with 5-HT2B receptor antagonist properties: absence of cardiac valvulopathy adverse drug reaction reports supports the concept of a crucial role for 5-HT2B receptor agonism in cardiac valvular fibrosis.

Clinical neuropharmacology·2006

Proterguride, a highly potent dopamine receptor agonist promising for transdermal administration in Parkinson's disease: interactions with alpha(1)-, 5-HT(2)- and H(1)-receptors.

Life sciences·2005

The origins of the fight against rabies: a journey between the history of neuroscience and university museum collections.

Functional neurology·2020

Are paediatric headaches in the emergency department increasing? An Italian experience.

Functional neurology·2020

Neurophysiological changes after cognitive-motor tasks in Parkinson's disease patients with deep brain stimulation.

Functional neurology·2020

Acute ischemic stroke management in Lebanon: obstacles and solutions.

Functional neurology·2020

Does a single bout of exercise impacts BDNF, oxidative stress and epigenetic markers in spinal cord injury patients?

Functional neurology·2020

Effects of Constraint-Induced Movement Therapy on upper limb activity according to a bi-dimensional kinematic analysis in progressive multiple sclerosis patients: a randomized single-blind pilot study.

Functional neurology·2020

[Sarcoidosis from an immunological perspective - experience-based diagnosis and treatment with targeted therapies].

Therapeutische Umschau. Revue therapeutique·2026

[Immune-related adverse events of immune checkpoint inhibitors].

Therapeutische Umschau. Revue therapeutique·2026

Therapeutic drug monitoring of adalimumab for dose optimization during maintenance therapy in patients with ulcerative colitis: real-world data.

Folia medica·2026

Correction: A robust and scalable immunoadsorbent platform based on the high-affinity M03-IgG antibody for targeted IL-6 Removal in cytokine storm.

Frontiers in immunology·2026

Expanded dendritic cells loaded with placental gp96 to generate antigen-specific T cells for anti-tumor immunity: an in vitro study.

Central-European journal of immunology·2026

Protein Posttranslational Modifications in Immunity: Molecular Mechanisms and Therapeutic Targets.

MedComm·2026

Related Experiment Videos

Neutralizing antibodies (NABS) and interferon beta-1b therapy of multiple sclerosis

Related Concept Videos

FG 7142: is this validated tool to study anxiety now forgotten?

Classical dopamine agonists.

Japanese medicine and Berlin: a very special and successful relationship.

The "Madness" of Friedrich Hölderlin: an iatrogenic intoxication.

Lisuride, a dopamine receptor agonist with 5-HT2B receptor antagonist properties: absence of cardiac valvulopathy adverse drug reaction reports supports the concept of a crucial role for 5-HT2B receptor agonism in cardiac valvular fibrosis.

Proterguride, a highly potent dopamine receptor agonist promising for transdermal administration in Parkinson's disease: interactions with alpha(1)-, 5-HT(2)- and H(1)-receptors.

The origins of the fight against rabies: a journey between the history of neuroscience and university museum collections.

Are paediatric headaches in the emergency department increasing? An Italian experience.

Neurophysiological changes after cognitive-motor tasks in Parkinson's disease patients with deep brain stimulation.

Acute ischemic stroke management in Lebanon: obstacles and solutions.

Does a single bout of exercise impacts BDNF, oxidative stress and epigenetic markers in spinal cord injury patients?

Effects of Constraint-Induced Movement Therapy on upper limb activity according to a bi-dimensional kinematic analysis in progressive multiple sclerosis patients: a randomized single-blind pilot study.

[Sarcoidosis from an immunological perspective - experience-based diagnosis and treatment with targeted therapies].

[Immune-related adverse events of immune checkpoint inhibitors].

Therapeutic drug monitoring of adalimumab for dose optimization during maintenance therapy in patients with ulcerative colitis: real-world data.

Correction: A robust and scalable immunoadsorbent platform based on the high-affinity M03-IgG antibody for targeted IL-6 Removal in cytokine storm.

Expanded dendritic cells loaded with placental gp96 to generate antigen-specific T cells for anti-tumor immunity: an in vitro study.

Protein Posttranslational Modifications in Immunity: Molecular Mechanisms and Therapeutic Targets.

Related Experiment Videos

Neutralizing antibodies (NABS) and interferon beta-1b therapy of multiple sclerosis

Related Concept Videos

Related Articles